China Sunsine is expecting to report a “material increase” in its consolidated net profit for the 1HFY2022 ended June.The expected growth in profit is attributable to the higher average selling price (ASP) on the back of the increase in prices of global commodities.The group was able to pass on ...

CGS-CIMB Research analyst Ong Khang Chuen has kept an “add” rating on China Sunsine Chemical Holdings with a lowered target price of 67 cents from 78 cents.China Sunsine reported a 1QFY2022 ended March net profit of RMB157 million up 26% y-o-y, above Ong’s expectations at 35% of his FY2022 for...

SPECIALTY rubber chemicals producer China Sunsine Chemical Holdings announced Thursday (Apr 28) that the group’s financial performance for the first quarter ended March has improved, despite lower sales volumes due to Covid-19-related lockdowns in China.

UOB Kay Hian’s analyst Adrian Loh as well as the Singapore research team has maintained their earnings per share (EPS) estimates for the FY2022 on all of the constituents in the Straits Times Index (STI) that are under their coverage.The team has given “buy” calls to all the counters, which in...

CGS-CIMB Research is keeping its “add” call on China Sunsine Chemical Holdings with an increased target price of 77 cents from 68 cents previously. Analyst Ong Khang Chuen likes the stock as the average selling price (ASP) of its products have increased, which should increase profits in FY2021, ...

Amala Balakrishner, a senior writer at The Edge Singapore, has been named “Most Promising Journalist of the Year” by the Securities Investors Association (Singapore). The award is given by SIAS, as part of the Corporate Governance Week organized by SIAS. Balakrishner received her award earlier t...

UOB Kay Hian analyst Clement Ho has kept his “buy” call with a target price of 69.5 cents for China Sunsine Chemical after the company reported a "strong" set of 1HFY2021 ended June results. In an August 23 research note, Ho highlights that China Sunsine’s 1HFY2021 of RMB265.2 million ($55.4 m...

KGI Research analyst Chen Guangzhi has maintained “outperform” on China Sunsine with a higher target price of 68 cents from 53 cents previously, as the company could see a turnaround in profitability in the FY2021, thanks to the upcycle in commodity prices and capacity ramp-up. That said, Chen s...

CGS-CIMB Research analysts Ong Khang Chuen and Kenneth Tan have maintained “add” on China Sunsine Chemical Holdings with a higher target price of 66 cents from 61 cents previously, following China Sunsine’s “positive 1Q business update” on April 29. “Our target price rises to 66 cents, s...

China Sunsine Chemical Holdings says it has seen an “overall improvement” y-o-y in the 1QFY2021 as it recorded sales revenue of RMB840 million ($171.7 million), 66% higher y-o-y. Gross profit margin (GPM) reached 31.6%. Net profit surged 274% y-o-y to RMB125 million. Sales volume during the quar...

The CEO of China Sunsine, Liu Jing Fu will be retiring on April 30. Liu, who was in the role since Nov 22, 2013, will be replaced by the group’s executive chairman Xu Cheng Qiu. Liu De Ming, the current general manager of China Sunsine’s main subsidiary, Shandong Sunsine Chemical, will be appoin...

As dimethylformamide (DMF) prices continue on a strong uptrend year-to-date (y-t-d), CGS-CIMB Research analysts Ong Khang Chuen and Kenneth Tan estimate that Jiutian Chemical Group will post a “record quarter” in 1QFY2021. More specifically, Ong and Tan forecast that Jiutian’s core net profit ...

CGS-CIMB Research has maintained its ‘add’ rating for China Sunsine Chemical Holdings with a higher target price of 61 cents from 55 cents previously due to an upward trend in average selling prices (ASPs). This comes following China Sunsine’s “solid set of results” for the 2HFY2020. ...

China Sunsine Chemical Holdings has reported 11% high earnings for the 2HFY2020 ended December of RMB136.4 million ($27.9 million), compared to earnings of RMB123.0 million in 2HFY2019. For the full-year, earnings fell 44% to RMB218.8 million from RMB388.9 million in FY2019 due to lower revenue aris...

CGS-CIMB Research has initiated coverage on Jiutian Chemical Group with an “add” call and a target price of 14.5 cents, as the brokerage sees the company riding on the dimethylformamide (DMF) cyclical upswing. The target price, according to analysts Lim Siew Khee, Ong Khang Chuen and Kenneth Tan...